ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

HYPR Hyperfine Inc

0,8121
-0,0151 (-1,83%)
Nach Börsenschluss
Zuletzt aktualisiert: 01:47:06
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Hyperfine Inc HYPR NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0151 -1,83% 0,8121 01:47:06
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,85 0,8027 0,85 0,8001 0,8272
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.4.202422:05BWHyperfine, Inc. to Announce First Quarter 2024 Financial..
23.4.202415:00BWHyperfine, Inc. Takes the Stage at ISMRM with Seventeen..
17.4.202415:00BWLeading Institutions Enroll First Alzheimer’s Patients..
21.3.202421:05GLOBEHyperfine, Inc. Reports Fourth Quarter and Full Year 2023..
21.3.202412:26IHMARKETNEWSU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs..
12.3.202414:00BWHyperfine, Inc. Collaborates with King’s College London to..
07.3.202422:30BWHyperfine, Inc. to Announce Fourth Quarter and Full Year..
28.2.202422:30BWHyperfine, Inc. to Present at the Oppenheimer 34th Annual..
21.2.202415:00BWHyperfine, Inc. Announces Collaboration with Athletic Heart..
16.2.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202414:00BWHyperfine, Inc. Celebrates Breadth of Swoop® System Data..
09.1.202415:00BWHyperfine, Inc. Launches AI-powered Brain Imaging Software..
24.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
21.11.202300:20EDGAR2Form 3/A - Initial statement of beneficial ownership of..
20.11.202315:00BWHyperfine, Inc. Announces Presentations on Clinical..
18.11.202301:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.11.202315:00BWHyperfine, Inc. to Present at the Piper Sandler 35th Annual..
09.11.202322:58EDGAR2Form 8-K - Current report
09.11.202322:43EDGAR2Form S-3 - Registration statement under Securities Act of..
09.11.202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:10EDGAR2Form 8-K - Current report
09.11.202322:05GLOBEHyperfine, Inc. Reports Third Quarter 2023 Financial Results
02.11.202314:15BWObservational Study Finds That Hyperfine, Inc. Portable MR..
19.10.202322:05BWHyperfine, Inc. to Announce Third Quarter Financial Results..
10.10.202322:05BWHyperfine, Inc. Announces Promotions of Two Key Clinical..
09.10.202315:00BWHyperfine, Inc. Receives FDA Clearance for Updated..
03.10.202322:07EDGAR2Form 8-K - Current report
07.9.202322:05BWHyperfine, Inc. to Present at Gilmartin Group Emerging..
17.8.202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.8.202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:11EDGAR2Form 8-K - Current report
14.8.202322:05GLOBEHyperfine, Inc. Reports Second Quarter 2023 Financial..
09.8.202315:00BWEnrollment Completed for HOPE PMR Pediatric Hydrocephalus..
24.7.202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.7.202322:05BWHyperfine, Inc. to Announce Second Quarter Financial Results..
18.7.202322:19EDGAR2Form 8-K - Current report
18.7.202322:05BWHyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D...
11.7.202315:00BWHyperfine, Inc. Launches Observational Study to Define New..
08.6.202315:00BWHyperfine, Inc. and the International Society for Magnetic..
18.5.202315:00BWHyperfine, Inc. Receives Grant for an Additional Three Years..
11.5.202322:05GLOBEHyperfine, Inc. Reports First Quarter 2023 Financial Results

Kürzlich von Ihnen besucht

Delayed Upgrade Clock